EMEA-000316-PIP03-20
Key facts
Invented name |
Entresto
|
Active substance |
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0315/2020
|
PIP number |
EMEA-000316-PIP03-20
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Prevention of heart failure
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Novartis Europharm Limited
E-mail: paediatric.enquiries@novartis.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|